One quarter of cancer patients are paying more than $20,000 in up-front doctors’ fees for their treatment, a new study suggests. Australian researchers linked data from 452 patients with melanoma and breast, prostate, lung and colorectal cancer to Medicare data on every consultation, tests, imaging, procedure and medication billed through the healthcare system. The study, ...
Already a member?
Enter your email to keep reading.